TuHURA Biosciences, Inc. (HURA)
NASDAQ · Manufacturing · Pharmaceutical preparations
HURA price, last 12 months
Key stats
- Previous close
- $1.37
- Open
- $1.39
- Day range
- $1.36 – $1.46
- 52-week range
- $0.4100 – $3.43
- Volume
- 202.5K
- Avg volume (20 days)
- 544.9K
- Market cap
- $88.6M
Performance
Technicals and fundamentals
About TuHURA Biosciences, Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $88.6M